AccordingtotheintroductionofSkyscapeMedpressoInc,AHFSDrugInformation(2020)isaMedicalappontheAndroidplatform.Thereiscurrentlya3.5.10versionreleasedonMar16,2020,youcanseethedetailsbelow.
AHFSDrugInformation®2020:the#1mostreliabledrugandsafetyresource.Monographscoverinformationonindications,dosageandadministration,contraindications,sideeffects,druginteractions,pharmacologyandpharmacokinetics,chemistryandstability,andmore.DESCRIPTION
Trustedbypharmacistsandotherhealthcareprofessionalsforover60years,AHFS®DI™isthemostcomprehensiveevidence-basedsourceofdruginformationcompletewiththerapeuticguidelinesandoff-labeluses.
AHFSDrugInformation®2020:istheonlydruginformationresourcecuratedbyanot-for-profitscientificorganizationandtheonlyremainingoriginalfederalcompendiumwhoseauthorityforestablishingacceptedmedicalusesincludesthebroadestscopeofdrugsandindicationsunderMedicaid,MedicarePartD,andmore.
Withexpandedandrevisedcontentsupportedbymorethan94,000referencesandincorporatingtheadviceofnumeroussubjectmatterexperts,AHFS®DI™helpsyouprotectyourpatients.
2020UpdatesInclude:
-Managementofopiateusedisorder
-Multimodalpainmanagementstrategiesfornon-opiateanalgesicagentsandopiate-sparingdrugs
-CurrentbestpracticesformanagementofpainandsedationincriticallyillpatientssuchastheconceptofanalgosedationandcomparisonsofvarioussedativeagentsusedforICUsedation
-NewlypublishedinformationonbreakthroughoncologydrugsapprovedaspartoftheFDA’sacceleratedapprovalprogram
-Updatingofpharmacogenomicconsiderationsrelatedtodosageadjustments(e.g.,tamoxifen)orriskofsensitivityreactions(e.g.,allopurinol,phenytoinorfosphenytoin)
-Expandedinformationonnon-oncologyoff-labeluses(e.g.,mycophenolateintreatingscleroderma;ketamineuseintreatment-resistantdepression)
-Additionofnewtherapiesforthetreatmentofseizuredisorders,includingstatusepilepticusandintractablechildhoodepilepsysyndromes
-UseofCalcitoninGene-RelatedPeptide(CGRP)antagonistsinthepreventivetreatmentofmigraines
-Importantchangesinmanagementofdiabetes,includingeffectsofSGLT2inhibitorsandGLP-1agonistsoncardiovascularriskreductionandbeneficialeffectsonrenalfunction
-SpecialFeature:Adiscussionofrecentevidencequestioningaspirin’sroleinprimarypreventionofcardiovasculareventsinmostadults,includingtheAmericanCollegeofCardiologyandAmericanHeartAssociation’spositions.